Andrej Valkov
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Vascular Tumors and Angiosarcomas
-
- Sarcoma Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Sarcoma Diagnosis and Treatment 3
- Prostate Cancer Treatment and Research 1
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Vascular Tumors and Angiosarcomas 1
- Co-authors
- Lill‐Tove Busund (17 shared papers)Roy M. Bremnes (17 shared papers)Tom Dønnem (17 shared papers)Thomas K. Kilvær (13 shared papers)Sveinung Wergeland Sørbye (13 shared papers)Eivind Smeland (13 shared papers)Sigve Andersen (5 shared papers)Nora Ness (3 shared papers)
In The Last Decade
Andrej Valkov
17 papers receiving 552 citations
Peers
Comparison fields: 5 of 46
- Oncology 246
- Pulmonary and Respiratory Medicine 219
- Cancer Research 99
- Immunology 124
- Gastroenterology 14
Countries citing papers authored by Andrej Valkov
This map shows the geographic impact of Andrej Valkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrej Valkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrej Valkov more than expected).
Fields of papers citing papers by Andrej Valkov
This network shows the impact of papers produced by Andrej Valkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrej Valkov. The network helps show where Andrej Valkov may publish in the future.
Co-authors
The 19 scholars most cited alongside Andrej Valkov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 93 | |
| 2 | 2011 | 80 | |
| 3 | 2017 | 61 | |
| 4 | 2012 | 42 | |
| 5 | 2014 | 35 | |
| 6 | 2011 | 32 | |
| 7 | 2012 | 29 | |
| 8 | 2010 | 29 | |
| 9 | 2012 | 23 | |
| 10 | 2012 | 22 | |
| 11 | 2014 | 22 | |
| 12 | 2012 | 20 | |
| 13 | 2011 | 19 | |
| 14 | 2011 | 18 | |
| 15 | 2014 | 17 | |
| 16 | 2010 | 12 | |
| 17 | 2013 | 3 |
About Andrej Valkov
Andrej Valkov is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Cardiology and Cardiovascular Medicine and Gastroenterology, having authored 17 papers that have together received 557 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (3 papers), MicroRNA in disease regulation (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cardiac tumors and thrombi (2 papers), Vascular Tumors and Angiosarcomas (1 paper), Prostate Cancer Treatment and Research (1 paper), Gastrointestinal Tumor Research and Treatment (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (246 citations), Pulmonary and Respiratory Medicine (219 citations), Cancer Research (99 citations), Immunology (124 citations) and Gastroenterology (14 citations). Andrej Valkov has collaborated with scholars based in Norway and Singapore. Frequent co-authors include Lill‐Tove Busund, Roy M. Bremnes, Tom Dønnem, Thomas K. Kilvær, Sveinung Wergeland Sørbye, Eivind Smeland, Sigve Andersen, Nora Ness, Elin Richardsen and Yngve Nordby. Their work appears in journals such as PLoS ONE, BMC Clinical Pathology, Sarcoma, Journal of Translational Medicine and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.